Myelofibrosis other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
== | ==Other Diagnostic Studies== | ||
[[ | ===''JAK2'' Mutation Analysis Testing=== | ||
*[[Reverse transcriptase polymerase chain reaction]] ([[RT-PCR]]) may be performed to observe the ''[[JAK2]]'' mutation. | |||
*''[[JAK2]]'' mutation on Val 617 Phe locus in 50% | |||
==References== | ==References== | ||
Revision as of 13:50, 10 March 2016
|
Myelofibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myelofibrosis other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Myelofibrosis other diagnostic studies |
|
Risk calculators and risk factors for Myelofibrosis other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Other Diagnostic Studies
JAK2 Mutation Analysis Testing
- Reverse transcriptase polymerase chain reaction (RT-PCR) may be performed to observe the JAK2 mutation.
- JAK2 mutation on Val 617 Phe locus in 50%